glp-1 lizard saliva Curious how a slow-moving sparked one of the biggest pharmaceutical breakthroughs of our time? The blockbuster drugs behind today's diabetes and weight-loss treatments have an origin story few people know A venomous lizard that eats

Subsequently, GSH levels were measured in astrocytes stimulated with 10 M cabergoline for different times, and the level of GSH was appreciably increased after 12 h (Fig

[ii] Krger, E., Shatokhina, E

The exploratory end points were PD parameters, including concentrations of fasting glucose, insulin, C-peptide, glucagon, free fatty acid, lipids, HbA1c and changes in BW, waist circumference and BMI

While these drugs are highly effective for weight loss and glycemic control, they are associated with gastrointestinal issues such as nausea, vomiting, and diarrhea, which can lead to treatment discontinuation among some patients For instance, clinical data and patient reports have shown that adverse events are particularly common during the early stages of treatment with drugs such as semaglutide and tirzepatide, prompting careful dose titration and medical supervision, which may not be feasible for all patients or healthcare settings Addressing these side effect concerns through better patient education, physician training, and next-generation formulations with reduced tolerability issues is crucial to improving long-term adherence and treatment outcomes